← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Wahlstrom Mats
10% Owner | Director
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001459154
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 1
- Purchases · 24M
- 3
- Average purchase
- $73.9K
- Median purchase
- $47.1K
- Gross purchase value
- $221.6K
Companies: TriSalus Life Sciences, Inc.
3 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-05-18 | TriSalus Life Sciences, Inc. | TLSI | Director | $151.8K | Open filing |
| 2024-11-25 | TriSalus Life Sciences, Inc. | TLSI | Director | 10% Owner | $22.8K | Open filing |
| 2024-11-22 | TriSalus Life Sciences, Inc. | TLSI | Director | 10% Owner | $47.1K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 3Small Sample | 100.0% (3/3) | 66.7% (2/3) | +2.1% | -0.3% | -7.8% |
| 20D | 3Small Sample | 100.0% (3/3) | 66.7% (2/3) | +15.7% | +14.1% | -9.0% |
| 60D | 3Small Sample | 100.0% (3/3) | 100.0% (3/3) | +35.8% | +45.7% | +21.0% |
| 120D | 2Small Sample | 100.0% (2/2) | 100.0% (2/2) | +26.9% | +26.9% | +18.4% |
Research patterns
- First purchase in 12M
- 1/2
- Large purchase ≥ $100k
- 1/3
- Cluster buying · 15D
- 1/3
- Buying the dip
- 3/3
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.